<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>114(3)</volume><submitter>Chowdhury SR</submitter><funding>Canadian Blood Services</funding><funding>Einstein Foundation Berlin</funding><funding>Einstein Stiftung Berlin</funding><funding>Canadian Institutes of Health Research</funding><funding>CIHR</funding><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Evidence-based protocols for managing bleeding emergencies in patients with immune thrombocytopenia (ITP) are lacking. We conducted a systematic review of treatments for critical bleeding in patients with ITP.&lt;h4>Methods&lt;/h4>We included all study designs and extracted data in aggregate or individually for patients who received one or more interventions and for whom any of the following outcomes were reported: platelet count response, bleeding, disability, or death.&lt;h4>Results&lt;/h4>We identified 49 eligible studies reporting 112 critical bleed patients with ITP, including 66 children (median age, 10 years), 36 adults (median age, 41.5 years), and 10 patients with unreported age. Patients received corticosteroids (n = 67), IVIG (n = 49), platelet transfusions (n = 41), TPO-</pubmed_abstract><journal>European journal of haematology</journal><pagination>458-468</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11798764</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review.</pubmed_title><pmcid>PMC11798764</pmcid><pubmed_authors>Strachan G</pubmed_authors><pubmed_authors>Arnold DM</pubmed_authors><pubmed_authors>Gill D</pubmed_authors><pubmed_authors>Fein S</pubmed_authors><pubmed_authors>Couban R</pubmed_authors><pubmed_authors>Chowdhury SR</pubmed_authors><pubmed_authors>Eisa K</pubmed_authors><pubmed_authors>Manski C</pubmed_authors><pubmed_authors>Guyatt G</pubmed_authors><pubmed_authors>Chowdhury MR</pubmed_authors><pubmed_authors>Porter S</pubmed_authors><pubmed_authors>Cooper N</pubmed_authors><pubmed_authors>Beck CE</pubmed_authors><pubmed_authors>Yan JW</pubmed_authors><pubmed_authors>Sirotich E</pubmed_authors><pubmed_authors>Pruitt B</pubmed_authors><pubmed_authors>Paynter D</pubmed_authors><pubmed_authors>Agarwal A</pubmed_authors><pubmed_authors>Mahamad S</pubmed_authors><pubmed_authors>Wen A</pubmed_authors><pubmed_authors>Kelton JG</pubmed_authors><pubmed_authors>Kang M</pubmed_authors><pubmed_authors>O'Connor C</pubmed_authors><pubmed_authors>-DiRaimo JM</pubmed_authors><pubmed_authors>Modi D</pubmed_authors><pubmed_authors>Cuker A</pubmed_authors><pubmed_authors>Grace RF</pubmed_authors><pubmed_authors>Zeraatkar D</pubmed_authors><pubmed_authors>Thabane L</pubmed_authors><pubmed_authors>Leong R</pubmed_authors><pubmed_authors>Pallapothu S</pubmed_authors><pubmed_authors>Xu E</pubmed_authors><pubmed_authors>de Wit K</pubmed_authors><pubmed_authors>Charness J</pubmed_authors><pubmed_authors>Nazaryan H</pubmed_authors><pubmed_authors>Kwon H</pubmed_authors><pubmed_authors>Dookie J</pubmed_authors><pubmed_authors>Breakey VR</pubmed_authors><pubmed_authors>Hassan Z</pubmed_authors><pubmed_authors>Pai M</pubmed_authors><pubmed_authors>Rathod P</pubmed_authors><pubmed_authors>Webert KE</pubmed_authors><pubmed_authors>Siddiqui I</pubmed_authors><pubmed_authors>Liu B</pubmed_authors><pubmed_authors>Venier LM</pubmed_authors><pubmed_authors>Shafiee A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review.</name><description>&lt;h4>Objectives&lt;/h4>Evidence-based protocols for managing bleeding emergencies in patients with immune thrombocytopenia (ITP) are lacking. We conducted a systematic review of treatments for critical bleeding in patients with ITP.&lt;h4>Methods&lt;/h4>We included all study designs and extracted data in aggregate or individually for patients who received one or more interventions and for whom any of the following outcomes were reported: platelet count response, bleeding, disability, or death.&lt;h4>Results&lt;/h4>We identified 49 eligible studies reporting 112 critical bleed patients with ITP, including 66 children (median age, 10 years), 36 adults (median age, 41.5 years), and 10 patients with unreported age. Patients received corticosteroids (n = 67), IVIG (n = 49), platelet transfusions (n = 41), TPO-</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-04-26T01:43:05.983Z</modification><creation>2025-04-06T10:13:24.404Z</creation></dates><accession>S-EPMC11798764</accession><cross_references><pubmed>39552264</pubmed><doi>10.1111/ejh.14351</doi></cross_references></HashMap>